Cited by

• Identification of the gene expression changes and gene regulatory aspects in ELF3 mutant bladder cancer.

  Guneri-Sozeri PY, Erkek-Ozhan S. Guneri-Sozeri PY, et al. Mol Biol Rep. 2022 Apr;49(4):3135-3147. doi: 10.1007/s11033-022-07145-2. Epub 2022 Feb 24. Mol Biol Rep. 2022. PMID: 35199247
• PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study.

  Hsu FS, Lin WC, Kuo KL, Chiu YL, Hsu CH, Liao SM, Dong JR, Liu SH, Chang SC, Yang SP, Chen YT, Chang RJ, Huang KH. Hsu FS, et al. Int J Mol Sci. 2021 Oct 28;22(21):11706. doi: 10.3390/ijms222111706. Int J Mol Sci. 2021. PMID: 34769137 Free PMC article.
• Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism.

  Elbadawy M, Sato Y, Mori T, Goto Y, Hayashi K, Yamanaka M, Azakami D, Uchide T, Fukushima R, Yoshida T, Shibutani M, Kobayashi M, Shinohara Y, Abugomaa A, Kaneda M, Yamawaki H, Usui T, Sasaki K. Elbadawy M, et al. Cancer Biol Ther. 2021 Jun 3;22(5-6):357-371. doi: 10.1080/15384047.2021.1919004. Epub 2021 May 26. Cancer Biol Ther. 2021. PMID: 34034619 Free PMC article.
• Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.

  Zhu Y, Liang S, Pan H, Cheng Z, Rui X. Zhu Y, et al. J Biosci. 2018 Jun;43(2):365-373. J Biosci. 2018. PMID: 29872024
• Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer.

  Shan L, Liu W, Zhan Y. Shan L, et al. Aging (Albany NY). 2019 Sep 23;11(18):7780-7795. doi: 10.18632/aging.102286. Epub 2019 Sep 23. Aging (Albany NY). 2019. Retraction in: Aging (Albany NY). 2024 Sep 30;16(18):12652-12653. doi: 10.18632/aging.206104. PMID: 31545294 Free PMC article. Retracted.